Evangelos Terpos, Eirini Katodritou, Evangelos Tsiftsakis, Efstathios Kastritis, Dimitrios Christoulas, Anastasia Pouli, Eurydiki Michalis, Evgenia Verrou, Konstantinos Anargyrou, Konstantinos Tsionos, Meletios A. Dimopoulos, Konstantinos Zervas. Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration. haematol [Internet]. 2009Feb.27 [cited 2024Apr.27];94(3):372-9. Available from: https://haematologica.org/article/view/5189